OncoSynergy Email Format

Biotechnology ResearchConnecticut, United States2-10 Employees

OncoSynergy is a biotechnology startup focused on developing cancer therapies, with a goal of delivering effective treatment in a single dose to improve patient survival and quality of life while minimizing side effects. The company originated as a spinoff from UCSF and the JLABS South San Francisco incubator, and is based in Stamford, Connecticut, near New York City. Its work centers on advancing a new class of cancer medicines and advancing its first clinical trial, which began in 2020 for glioblastoma, an aggressive brain tumor. The organization operates with a small team and positions itself within the biotechnology research sector, aiming to address complex oncological challenges through patient-centered research. A recent development noted is a collaboration announced in 2019 with Infuseon Therapeutics, alongside noted neuro-oncology leadership from Moffitt Cancer Center, reflecting its engagement with external partners in pursuing its clinical objectives.

Get verified OncoSynergy emails free

Company overview Employee directory